From Casetext: Smarter Legal Research

Sanofi-Aventis Deutschland GmbH v. Genentech, Inc.

United States Court of Appeals for the Federal Circuit
Sep 11, 2012
2012-1454 (Fed. Cir. Sep. 11, 2012)

Opinion

2012-1454

09-11-2012

SANOFI-AVENTIS DEUTSCHLAND GMBH, Plaintiff-Appellee, v. GENENTECH, INC., Defendant-Appellant, AND BIOGEN IDEC INC., Defendant.


NOTE: This order is nonprecedential.


Appeal from the United States District Court for the

Northern District of California in consolidated case nos.

08-CV-4909 and 09-CV-4919, Judge Susan Illston.


ON MOTION


ORDER

Genentech, Inc. moves for the court to schedule oral argument in the case in September. Sanofi-Aventis Deutschland GmbH opposes.

By the time the motion was received by the court, the September calendar had been scheduled. The court previously denied a motion to expedite oral argument.

Upon consideration thereof,

IT IS ORDERED THAT:

The motion is denied. Oral argument will be scheduled in the usual course.

FOR THE COURT

______________

Jan Horbaly

Clerk
cc: William E. Solander, Esq.

Charles K. Verhoeven, Esq.
s26


Summaries of

Sanofi-Aventis Deutschland GmbH v. Genentech, Inc.

United States Court of Appeals for the Federal Circuit
Sep 11, 2012
2012-1454 (Fed. Cir. Sep. 11, 2012)
Case details for

Sanofi-Aventis Deutschland GmbH v. Genentech, Inc.

Case Details

Full title:SANOFI-AVENTIS DEUTSCHLAND GMBH, Plaintiff-Appellee, v. GENENTECH, INC.…

Court:United States Court of Appeals for the Federal Circuit

Date published: Sep 11, 2012

Citations

2012-1454 (Fed. Cir. Sep. 11, 2012)